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Cys loop, glutamate, and P2X receptors are ligand-gated ion channels (LGICs) with 5, 4, and 3 protomers, respectively. There is now growing atomic level understanding of their gating mechanisms. Although each family is unique in the architecture of the ligand-binding pocket, the pathway for motions to propagate from ligand-binding domain to transmembrane domain, and the gating motions of the transmembrane domain, there are common features among the LGICs, which are the focus of the present review. In particular, agonists and competitive antagonists apparently induce opposite motions of the binding pocket. A simple way to control the motional direction is ligand size. Agonists, usually small, induce closure of the binding pocket, leading to opening of the channel pore, whereas antagonists, usually large, induce opening of the binding pocket, thereby stabilizing the closed pore. A cross-family comparison of the gating mechanisms of the LGICs, focusing in particular on the role played by ligand size, provides new insight on channel activation/ inhibition and design of pharmacological compounds.
Common threads of LGICs
As with change in transmembrane voltage, ligand binding is a common stimulus for ion channels. The term LGICs often specifically refers to three families of ionotropic receptors: Cys loop receptors [in particular, nicotinic acetylcholine receptors (nAChRs)], ionotropic glutamate receptors (iGluRs), and P2X receptors (P2XRs). The functional units of these receptors are all oligomers comprising identical or homologous protomers, but the numbers of protomers differ ( Figure 1 ) [1] [2] [3] . Cys loop receptors, iGluRs, and P2XRs have 5, 4, and 3 protomers, respectively. In each family, the minimum construct for channel function consists of an extracellular domain (to be referred to as the ligand-binding domain, or LBD) that harbors the ligand-binding sites, and a transmembrane domain (TMD) that contains the pore for ion permeation, with additional domains that play other functional roles such as regulation of channel activity and trafficking. The ligand-binding sites are located in the interprotomer interfaces for Cys loop receptors and P2XRs, but in the cleft between two lobes of each LBD protomer for iGluRs ( Figure 1 ). With a significant amount of structural and mechanistic knowledge accumulated for each family of LGICs, it now seems appropriate to look for common lessons.
A common set of questions that define the gating mechanisms of all the LGICs is: What rearrangement of the binding sites does ligand binding induce? How are the motions of the LBD propagated to the TMD? And what are the motions of the pore-lining helices that are responsible for pore opening/closing? Given their distinct molecular architectures, the three families of LGICs are expected to have different solutions to these questions. However, as suggested recently [4] , the different LGICs could have some common elements in their gating mechanisms. The gating mechanisms provide the basis for understanding ligand actions and designing pharmacological compounds. This review focuses on ligand size as a common factor in affecting ligand actions on the three families of LGICs.
Significant advance in the understanding of the gating mechanisms of Cys loop receptors and iGluRs was made by comparing the structures of the LBDs bound with various agonists and antagonists. For Cys loop receptors, this was made possible by the fact that the LBD is homologous to a water-soluble, homopentameric acetylcholine-binding protein (AChBP) [5] . For iGluRs, this was made possible by constructs in which the TMD is removed, and the open Review Glossary Mutant cycle analysis: a way to obtain information on the contribution of the interaction between two neighboring residues to channel gating, by studying the effects of mutating these residues. The perturbations of the two single mutations and the double mutation on the free energy difference between open and closed states of the channel (from measuring single channel dwell times) are obtained. A significant deviation of the effect of the double mutation from the sum of the effects of the two single mutations indicates the importance of the interaction between the two residues in channel gating. Normal mode analysis: a modeling approach to obtain functionally important conformational changes of a protein. The motions of the protein are modeled as harmonic. By solving an eigenvalue problem, harmonic modes are obtained. Typically, some of the low frequency modes, which involve collective motions of a large fraction of the atoms, are assumed to be associated with biological function. Rate equilibrium free energy relation: a way to assess whether the environment of a residue in the transition state for channel opening is more similar to that in the closed state or that in the open state. Mutations on the residue are made and their effects on the activation energy for channel opening and on the free energy difference between open and closed states are obtained. The former are then expressed as a fraction of the latter. A fraction close to 0 indicates that the environment of the residue in the transition state is similar to that in the closed state; a fraction close to 1 indicates that the environment of the residue in the transition state is similar to that in the open state. Substituted cysteine accessibility method: a given residue in a channel protein is mutated into cysteine and a cysteine modifying agent is then applied in the absence and presence of an agonist. The change in modification rates is interpreted as indicating whether the residue becomes more or less accessible upon channel activation. Targeted molecular dynamics simulation: a part of a protein is forced to move in a given direction, and the goal is to see how the rest of the protein responds in the simulation. In particular, a part of the ligand-binding domain may be moved to mimic the motion induced by an agonist, and the response of the transmembrane domain may suggest a gating mechanism. Corresponding author: Zhou, H-X. (hzhou4@fsu.edu). ends are then connected by a short peptide linker [6, 7] . By comparing the iGluR LBD structures bound with agonists, partial agonists, and competitive antagonists, Armstrong and Gouaux [7] observed that agonists induce significant cleft closure, partial agonists do so to a lesser extent, and antagonists keep the LBD in the open cleft conformation. Hansen et al. [8] similarly observed that the AChBP C loop closes down on a nAChR agonist but opens up when an antagonist is bound. This observation was confirmed recently by a comparison of AChBP structures bound with various agonists and antagonists [9] .
In developing a model for nAChR activation and inhibition, it was further observed that small ligands can fit better into a closed-down binding pocket, whereas larger ligands can fit better into an opened-up binding pocket, leading to the conclusion that agonists tend to be small and antagonists tend to be large [10] . As shown below, a systematic analysis of the available AChBP and iGluR LBD structures generally supports this conclusion. Although no antagonist-bound structure is yet available for any P2XR, structural models obtained from molecular dynamics simulations [4] suggest that the same conclusion may extend to P2XRs as well. It seems that ligand size is a key determinant in the activation/inhibition of all the three families of LGICs. Agonists, usually small, induce closure of the binding pocket, leading to opening of the channel pore, whereas competitive antagonists, usually large, induce opening of the binding pocket, thereby stabilizing the closed channel pore. This review pays only passing attention to inverse agonists, which close spontaneously open channels, and allosteric modulators, which bind the receptors at sites distinct from the agonist-binding sites.
Cys loop receptors
In addition to nAChRs, the Cys loop family also includes 5-hydroxytryptamine (5-HT), g-aminobutyric acid, and glycine receptors, and glutamate-gated chloride channels (GluCl); the first two are cation-selective, whereas the last three are anion-selective. In the LBD, each protomer comprises two b-sheets (Box 1). The C loop, connecting b9 and b10 in the outer sheet, moves a considerable distance to accommodate the bound ligand (Figure 2a) . At the apex of the C loop is a pair of adjacent Cys residues (at positions 189 and 190 in the homomeric neuronal a7 nAChR) that form a disulfide bond. Among 31 AChBP structures in the Protein Data Bank (PDB), the distances between the first C loop Cys residues of two neighboring protomers (d Cys-Cys ) span a wide range, from 35.5 to 48.4 Å ( Table 1) . A shorter interprotomer d Cys-Cys signifies closing down of the C loop, whereas a longer d Cys-Cys signifies opening up of the C loop. Confirming previous observations [8, 9] , histograms in d Cys-Cys (Figure 2b) show that agonist-bound structures tend to have the C loop closed down, antagonist-bound structures tend to have the C loop opened up, and partial agonist-bound structures have intermediate opening of the C loop.
The information in Table 1 also provides support to the notion that small ligands fit better into a closed-down binding pocket, whereas larger ligands fit better into an opened-up binding pocket [10] . Among 27 structures bound with nonpeptide ligands, there is a moderate correlation (R 2 = 0.48) between d Cys-Cys and ligand molecular weight (Figure 2c ). The peptide ligands have much higher molecular weights (although in each case much of the molecular weight may be positioned outside the ligand-binding pocket) and correspond to larger d Cys-Cys values, further buttressing the trend.
The outliers in the correlation plot of Figure 2c are interesting. In PDB 2XNV, the ligand is 2-[2-(4-phenylpiperidin-1-yl)ethyl]-1H-indole (compound 6 from an in silico screening) (Figure 2d ), an a7 nAChR antagonist [11] . The bound ligand adopts a wedge-shaped conformation, with the indole and phenyl rings forming the two adjoining faces. The indole ring is stacked against the C loop of (c) Zebra fish P2X4 receptor in the apo form (PDB entry 3H9V) [3] . ATP in the 'distal' orientation, which was suggested to stabilize the closed state by molecular dynamics simulations [4] , is built into the putative binding site.
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Trends in Pharmacological Sciences September 2012, Vol. 33, No. 9 the protomer on the 'principal' side, whereas the phenyl ring is stacked against strand b2 (in particular residue Y53, corresponding to a7 W54) of the protomer on the 'complementary' side. [On the principal side, ligands are commonly found to contact several aromatic residues, including Y92, W148, Y187, and Y194, as well as C190 (a7 numbering) at the apex of the C loop (Box 1).] The wedge shape, with the tips of the two apposing rings 7 Å apart, allows the ligand to expend a minimal number of atoms to achieve a significant opening of the C loop. The ligand in PDB 2XNT, (2s)-2-[(4-chlorobenzyl)oxy]-2-phenylethanamine, behaves in much the same way. Again, a wedge-shaped ligand is positioned as if to pry open the interprotomer interface.
By contrast, the situation is very different in the structure of AChBP bound with lobeline (PDB 2BYS) [8] , an agonist ( Figure 2e ). The bound lobeline adopts an extended conformation, with the two terminal phenyl rings maximally separated from each other. The slender ligand is positioned nearly vertically, with the midsection surrounded by the C loop on the principal side and by b2 Y53 on the complementary side. The two terminal phenyl rings form additional interactions: one positioned at the top interacting with the complementary side and the other positioned at the bottom interacting with the principal side. Lobeline thus distributes its atoms away from the C loop, explaining why a relatively high molecular weight ligand can still reside entirely in a binding pocket with a
Box 1. Sequences and functionally important motifs in three families of LGICs
The sequence alignment of several AChBPs and the LBDs of several Cys loop receptors is as follows: 3A 
Ac AC hBP 6 RLKSD LFN --RSPMY PGPTKD DPL TVTLGFT LQDIVK VDS STNEVDL VYYEQQ RWK LNSLMWD -PNEYG NI Bt AC hBP 4 WTLLN QITG--ESDV IPLSNN TPL NVSLNFK LMNIVE ADT EKDQVEV VLWTQA SWK VPYYSSL LSS --SSL Ls AC hBP 4 ADILY NIR QTSRPDV IPTQRD RPV AVSVSLK FINILE VNE ITNEVDV VFWQQT TWS DRTLAWN -SS --HSP α7 nAChR 5 KLYKE LVK NYNPLER PVANDS QPL TVYFSLS LLQIMD VDE KNQVLTT NIWLQM SWT DHYLQWN -VSEYP GV nAChR α 6 RLVAN LLE NYNKVIR PVEHHT HFV DITVGLQ LIQLIN VDE VNQIVET NVRLRQ QWI DVRLRWN -PADYG GI 5-HT

RLSDH LLA NYKKGVR PVRDWR KPT TVSIDVI MYAILN VDE KNQVLTT YIWYRQ YWT DEFLQWT -PEDFD NV
Ac AC hBP 74 TDFRT SAA DIWTPDI TAYSST RPV -QVLSPQ IAVVTH DGS VMFIPAQ RLSF MCDPT GVDS-EE GVT CAV KF Bt AC hBP 71 DQVSL PVS KMWTPDL SFYNAI AAP -ELLSAD RVVVSK DGS VIYVPSQ RVRF TCDLI NVDT-EP GAT CRI KV Ls AC hBP 72 DQVSV PIS SLWVPDL AAYNAI SKP -EVLTPQ LARVVS DGE VLYMPSI RQRF SCDVS GVDT-ES GAT CRI KI
Ac AC hBP 143 GS WVY SGF EIDLK----TD-TDQV DLSSYYA -SSKYE ILS ATQTRQV QHYSCC PE-PYIDVNL VVKFRE Bt AC hBP 140 GS WTH DNK QFALI----TGEE GVV NIAEYFD -SPKFD LLS ATQSLNR KKYSCC EN-MYDDIEI TFAFRK Ls AC hBP 141 GS WTH HSR EISVD----PT-TENS DDSEYFS QYSRFE ILD VTQKKNS VTYSCC PE-AYEDVEV SLNFRK α7 nAChR 146 GSWSY GGW SLDLQ-------MQEA DISGYIP -NGEWD LVG IPGKRSE RFYECC KE-PYPDVTF TVTMRR nAChR α 147 GIWTY DGT KVSIS----PE-SDRP DLSTFME -SGEWV MKD YRGWKHW VYYTCC PDTP YLDITY HFIMQR 5-HT 3A 180 TSWLH TIQ DINITLW RSPE-EVRS DKSIFIN -QGEWE LLE VFPQFKE FS-IDI SN-SYAEMKF YVIIRR
Cys loop
C loop
The LBD has 10 b-strands per protomer. b1, b2, b3, b5, and b6 form the inner sheet, with the remaining four strands (b4, b7, b9, and b10) forming the outer sheet. The loop connecting b9 and b10 is commonly referred to as C loop; the loop connecting b6 and b7 has a conserved pair of disulfide-bonded Cys residues (orange letters), and is referred to as the Cys loop, which is the namesake for the protein family. Ligands are commonly found to contact C190 (orange letter; a7 numbering) at the apex of the C loop and several aromatic residues, including Y92, W148, Y187, and Y194 on the principal side and W54 on the complementary side (green letters; a7 numbering).
The TMD of a Cys loop receptor has four a-helices per protomer; M2 lines the pore. The b1-b2 loop, Cys loop, and M2-M3 linker are positioned at the LBD-TMD interface [1, [16] [17] [18] , and are involved in propagating motions from the LBD to the TMD (Box 2).
The sequence and domain separation of the GluR2 AMPA receptor are shown below: 
(D2) 789 (M4)
The LBD consists of two lobes, D1 and D2, as indicated by dark and light blue letters in the sequence. In the resting state structure [2] (Figure 1b) , the pore-lining M3 helices are longer by four residues in the 'proximal' (chains A and C) protomers than in the 'distal' (chains B and D) protomers. The C-terminal portion of the M3 helix contains the conserved SYTANLAAF motif and the channel gate.
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Trends in Pharmacological Sciences September 2012, Vol. 33, No. 9 closed C loop. Clearly, ligand size alone has its limitation in predicting ligand action. Reinforcing this point, a ligand can change from a partial agonist for one receptor subtype to a full or 'super' agonist for another receptor subtype [12] , or even from a competitive antagonist for the wild type channel to an agonist for a mutant channel [13] . In addition, some competitive antagonists can also act, perhaps with the same mechanism of action, as inverse agonists for constitutively active mutant channels [14] .
Although the most noticeable conformational change induced by agonists and antagonists is the movement of the C loop, in some agonist-bound structures, the rest of the LBD also seems to undergo conformational change (Figure 2a ). In particular, the outer b-sheet appears to undergo a clockwise rotation (top view) around an axis that divides the two b-sheets. Based, in part, on a comparison between the 4-Å electron microscopy structure of the heteromeric muscle nAChR in the apo form and the structure of carbamylcholine-bound AChBP (PDB 1UV6; [15] ), Unwin [1] proposed that the clockwise rotation is involved in channel activation. Recently, the structures of two bacterial homologs, ELIC and GLIC, of Cys loop receptors were determined [16] [17] [18] . Putatively ELIC is in the closed state and GLIC is in the open state. Because ELIC and GLIC have low sequence identity (20%), there is no unique way to align their structures, and different alignments have led to varying speculations on the motions of the extracellular domain that may trigger channel opening [17] [18] [19] [20] . In particular, Zimmermann and Dutzler [19] suggested that a counterclockwise rotation, opposite to what was proposed by Unwin [1] , of the extracellular domain leads to channel opening. Computational studies have also produced an assortment of models for LBD motions [10, [20] [21] [22] [23] [24] [25] [26] .
The structures of ELIC and GLIC do unequivocally show that the external end of the pore-lining M2 helix undergoes an outward tilt to open the pore [17, 18] . That an M2 tilt constitutes the gating motion is supported by functional studies [27, 28] and by a recent structure of a GluCl channel in the putative open state [29] . So for Cys loop receptors, there is now broad consensus that agonistinduced channel activation begins with the closing down of the C loop and ends with the outward tilt of the M2 helix. However, what additional motions are involved in between and how the motions are propagated remain unsettled [30, 31] 
(Box 2).
Glutamate receptors iGluRs are divided into three main subtypes: a-amino-3-hydroxyl-5-methyl-4-isoxazole propionic acid (AMPA), Nmethyl-D-aspartate (NMDA), and kainate receptors. In 2009, the structure of a nearly full-length AMPA receptor (GluR2 homomeric) in the antagonist-bound form was determined [2] . This structure reveals that the LBD is a dimer of dimers, with limited contact between the dimers, 9 whereas the TMD has 4-fold symmetry, with helix M3 lining the pore (Figure 1b) . All other iGluR structures in the PDB are for the isolated LBD (in dimeric form), with the most entries for the GluR2 AMPA receptor. In each protomer, the LBD consists of two lobes, referred to as D1 and D2, that form a clamshell structure (Figure 3a) . Depending on the ligand bound at the interlobe cleft, the opening of the clamshell, as measured by the distance (d K410-K695 ) between residue K410 near the tip of D1 and residue K695 near the tip of D2 (GluR2 numbering; Box 1), varies widely, from 24.7 to 31.0 Å ( Table 1) . As observed by Armstrong and Gouaux [7] , agonists close the clamshell to a greater extent than partial agonists, whereas antagonists keep the clamshell open (Figure 3a,b) .
Box 1 (Conitued ).
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Here again ligand size appears to be a determinant for the extent of the binding pocket opening. There is reasonable correlation (R 2 = 0.58) between d K410-K695 and ligand molecular weight (Figure 3c ). The trends shown by the histograms of Figure 3b and the correlation plot of Figure 3c for the GluR2 AMPA receptor are also seen for kainate receptors (there are too few NMDA receptor LBD structures in the PDB for statistical analysis). For both nAChRs and iGluRs, it takes 70 Da of ligand molecular weight to increase the binding pocket opening by 1 Å .
Based on a comparison of the GluR2 LBD dimer structures bound with either an agonist (AMPA) or an antagonist (DNQX), Sun et al. [32] speculated that agonist-induced closure of the clamshell moves the tip of the D2 lobe away from the central axis, and this opens the channel pore. The structure of the nearly full-length GluR2 AMPA receptor in the resting state [2] showed that the outward movement of the D2 tip would drag the M3-D2 linker, which in turn pulls the M3 helix outward. Moreover, at the level of the M3-D2 linkers, the diagonal pair of protomers (chains B and D) distal to the central axis moves much more than the proximal pair (chains A and C), and hence contributes more to channel activation. Atomistic details of how agonist binding induces channel opening are revealed by targeted molecular dynamics simulations (see Glossary) [33] . The resulting activation model explains many observations in functional studies, in particular the correlation between the extent of ligand-induced LBD closure and the degree of channel activation [7, 34] 
(Box 2).
LGICs become desensitized in the sustained presence of an agonist. For iGluRs, significant structural information is available for the desensitized state (this is in contrast to the lack of such information for Cys loop receptors). Desensitization involves the disruption of the D1-D1 dimeric interface [35] [36] [37] . A model for the LBD dimer in the desensitized state was created by introducing a disulfide bond in the D2-D2 dimeric interface (which leads to separation of the D1-D1 dimeric interface) [36] . Targeted molecular dynamics simulations showed that the separation of the D1-D1 dimeric interface pushes the D2-M3 linkers inward, thus largely reversing the motions seen during channel activation and leading to the closing of the pore [33] .
P2X receptors
In mammals there are seven subtypes of P2XRs, denoted as P2X1 to P2X7 receptors. From a structural point of view, P2XRs have been the least well characterized among the three families of LGICs, but the recent determination of the zebrafish P2X4 receptor (zP2X4R) in the apo form [3] ( Figure 1c ) is changing the situation [38, 39] . Previous mutational studies [40] [41] [42] [43] [44] [45] identified four conserved charged residues, K70, K72, R298, and K316 (zP2X4R number; Box 1), as part of the ATP-binding site. These four residues are clustered at the interprotomer interface, with K70 and K72 on strand b1 of one protomer, and R298 on strand b13 and K316 on strand b14 of another ( Figure 4) ; b1 and b14 are connected to TMD helices M1 and M2, respectively, the latter lining the pore (Figure 1c) . Recent functional studies have illuminated the gating mechanism of P2XRs. The channel gate is located at the external portion of the M2 helix [46, 47] . Permeant ions probably access the transmembrane pore via the lateral fenestrations located just above the TMD [48, 49] .
By crosslinking 8-thiocyano-ATP (NCS-ATP) with single cysteine substitutions around the putative binding site, Jiang et al. [50] have now obtained evidence that NCS-ATP can bind in two opposite orientations (Figure 4) . One has the adenine ring on the TMD proximal side of the four charge cluster (FCC) and the other has the ring on the TMD distal side. (A precedent for opposite ligand orientations was reported for an AChBP [51] .) Interestingly, ATP-gated currents were potentiated by labeling NCS-ATP in the 'proximal' orientation but inhibited in the 'distal' orientation.
To elucidate a possible gating mechanism, Du et al. [4] carried out a normal mode analysis of the apo zP2X4R structure. A normal mode involving coupled motions of b1, b13, b14, and M2 was identified (see Figure Ic in Box 2). In particular, the pre-M2 loop expanded outward. The resulting widening of the fenestrations above the TMD and opening of the transmembrane pore bear signatures of channel activation. The authors then docked ATP near the FCC in two opposite orientations, with the adenine either proximal or distal to the TMD, and followed with parallel molecular dynamics simulations (Figure 4 ). In the simulations with the proximal orientation, the ATP molecule became wedged between b13 and b14 of one protomer and b1 of the neighboring protomer, acting as a fulcrum that turned modest closure of the FCC into significant outward expansion of the pre-M2 loop. The simulations thus hint at how ATP binding triggers channel activation. The gating mechanism suggested by the computational studies explains the potentiation effect of NCS-ATP labeled in the 'proximal' orientation as well as many other observations in functional studies (Box 2). Very recently, Hattori and Gouaux [52] determined a structure for zP2X4R in the ATP-bound form. This structure confirms key elements of the proposed gating mechanism, including an outward expansion of the pre-M2 loop. ATP is bound to a location similar to that in the simulations, but adopts a different conformation, with the adenine positioned to the [11] . The C loop is on the left and in red; b2 is on the right and in blue. (e) Lobeline bound to Aplysia californica AChBP (PDB entry 2BYS) [8] .
Box 2. Gating mechanisms of three families of LGICs
The understanding of ligand actions on the three families of LGICs requires an understanding of their gating mechanisms. To provide the basis for rationalizing the proposed correlation between ligand size and ligand action, the current knowledge on the propagation of motions from the LBDs to the TMDs and the gating motions of the TMDs is summarized below. Many studies of Cys loop receptors have suggested that the b1-b2 loop, Cys loop, and M2-M3 linker, positioned at the LBD-TMD interface [1, [16] [17] [18] (Figure Ia) , are involved in propagating motions from the LBD to the TMD in triggering channel opening [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] . Using mutant cycle analysis, Sines and coworkers [64, 69, 70] identified a pathway, consisting of strongly coupled residues, for example, between V46 in the b1-b2 loop and P272 in the M2-M3 linker (muscle nAChR a protomer numbering), across the LBD-TMD interface. Based on rate equilibrium free energy relations, Auerbach and coworkers [59, 63, 68] further suggested that agonist binding generates a wave that propagates from the ligand-binding site to the b1-b2 loop and Cys loop, then to the M2-M3 linker, and finally down the M2 helix. The substituted cysteine accessibility method (SCAM) indicates that, upon channel activation, the lower end of b1 in a7 nAChR becomes less accessible but the lower end of b2 becomes more accessible [71] . Change in the propensity of substituted cysteines to form disulfide bonds between the b1-b2 loop and M2-M3 linker of a 5-HT 3 receptor suggests that these two elements move apart during channel activation [66] .
Still unclear is the mechanism by which the motions at the ligandbinding site are propagated across the LBD-TMD interface to drive the outward tilt of the external end of the pore-lining M2 helix. An idea that has been repeatedly raised is that the resting state conformation is strained; agonist binding acts to relieve the strain and opens the pore as a result. Unwin [1] suggested that the strain is manifested by lack of 5-fold symmetry in the LBD of the muscle nAChR. Specifically, the two a protomers, whose C loops provide the ligand-binding sites, are rotated relative to the three non-a protomers. Lee et al. [69] considered the apo LBD as a brake that maintains a closed channel pore; ligand binding disengages the LBD from the TMD, allowing the pore to open. Similarly, Hilf and Dutzler [17] envisioned breaking an unidentified critical interaction in the LBD-TMD interface.
outside, not inside, of the triphosphate group. In the molecular dynamics simulations with the distal orientation, ATP appeared to stabilize the tightening of the surrounding trimeric interface and the closure of the pre-M2 loop, possibly representing a desensitized state.
Many P2XR antagonists have been identified [53] [54] [55] , including a subtype nonselective, competitive antagonist called suramin. A mutational study [56] identified K138 in the human P2X1 receptor (corresponding to D141 in zP2X4R) as a possible suramin-interacting residue. In the zP2X4R structure, this residue is located on the distal side of the FCC (Figure 4b ). This lends support to the suggestion that competitive antagonists may occupy the wider interprotomer ridge above the FCC (similar to ATP in the distal orientation), thereby maintaining the closure of the pre-M2 loop. Many other P2XR antagonists are described as noncompetitive, and their binding sites remain unknown [53] [54] [55] .
Insight for designing pharmacological compounds
The three families of LGICs are involved in many human diseases and are known drug targets. Structural information and mechanistic understanding are undoubtedly Figure Ib illustrates the mechanism of GluR2 AMPA receptor activation developed from targeted molecular dynamics simulations [33] . As previously suggested by Sobolevsky et al. [2] , the outward motion of each 'distal' D2 tip drags the M3-D2 linker, which in turn pulls outward the external end of the pore-lining M3 helix, opening the pore and distorting the 4-fold symmetry. The whole TMD also moves upward, such that the D2 lobes stay anchored on top of the cell membrane. Moreover, the diagonal pairs of M3-D2 linkers rotate relative to each other in the lateral plane, so that the four linkers are positioned more in line with 4-fold symmetry. It is as though the abrupt transition between the 2-fold symmetry of the M3-D2 linkers and the 4-fold symmetry of the M3 helices in the resting state builds up a strain, which, upon agonist binding, drives the relative rotation between the proximal and distal pairs of M3-D2 linkers.
This activation model explains many observations in functional studies, including the pattern of agonist-induced accessibility changes from SCAM measurements of the M3 external portion [72] ; the 2-fold symmetry of the outer pore in the activated state [73] ; and the effect of M3-D2 linker charge mutations on channel desensitization [74] . One could now also see why the extent of ligand-induced LBD closure is correlated with the degree of channel activation [7, 34] . As illustrated in Figure Ib , the closure of the D2 lobe is directly translated into the outward movement of the M3 external end and channel opening. Therefore, the greatest LBD closure, as induced by agonists, opens the channel to the greatest extent. Moderate closure of the LBD clamshells, as induced by partial agonists, opens the channel to a moderate extent. The open LBD conformation, as maintained by antagonists, keeps the channel closed.
By combining normal mode analysis and molecular dynamics simulations, Du et al. [4] developed a gating mechanism for P2X4R (described in the main text; Figure Ic ). The atomistic model produced both a pattern of ATP-induced accessibility changes in M1 and M2 that is consistent with SCAM measurements [46, 75] and the observed expansion of the lateral fenestrations [48] . It also explains why an interprotomer disulfide bond (presumably leading to interface closure) above the FCC potentiates the ATP-activated current [48] , whereas a disulfide bond below the FCC has a reduced rate of formation in the presence of ATP [76] .
A lipophilic compound ivermectin acts as a positive allosteric modulator of P2X4R. Ivermectin, extending 20 Å in length, was suggested by mutational studies [77, 78] to be inserted between the M1 and M2 helices. As shown in Figure Ic , the spacing between M1 and M2 increases upon channel opening, providing room for ivermectin. Therefore, by preferentially binding, ivermectin may stabilize the open state, as previously proposed [79] . A similar effect of ivermectin was established by the putative open structure of a GluCl channel with ivermectin wedged between the M1 and M3 helices of two neighboring protomers [29] . valuable for antagonist design. For both Cys loop receptors and iGluRs, it seems clear that competitive antagonism requires sufficient opening of the ligand-binding pocket, which in turn requires ligands with sufficient sizes. There are hints that the same may apply to P2XRs as well.
However, for ligands to become drugs, molecular weight (a measure of molecular size) is a premium. Compound 6, an a7 nAChR antagonist [11] , points a way for eliciting maximal binding pocket opening with a minimal molecular weight. The wedge shape of the molecule is ideally suited to pry open the binding pocket. It will be interesting to see [50] and refined by molecular dynamics simulations [4] . (a) ATP bound in the 'proximal' orientation. Side chains of the four charge cluster, interacting with the triphosphate group, are shown. The backbone carbonyl of G294 forms a hydrogen bond with the adenine group. L191 corresponds to a position where NCS-ATP was labeled [50] . (b) ATP bound in the 'distal' orientation. D145 corresponds to a second position where NCS-ATP was labeled [50] The antagonist suramin perhaps binds in a similar mode. D141 corresponds to a position implicated in suramin binding [56] .
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Trends in Pharmacological Sciences September 2012, Vol. 33, No. 9 whether the same design can be adapted for iGluR and P2XR antagonists. With more and more structures available for the LGICs, in silico screening has become increasingly useful for identifying high-affinity ligands [11, 57, 58] . Experimental verification is essential. In silico screening by Akdemir et al. [11] successfully identified compound 6, but not the docking pose in the crystal structure (PDB 2XNV). In the docking simulation the ligand adopted an extended conformation, instead of the wedge-shaped folded conformation in the crystal structure.
Subtype selective antagonists are more useful as drug leads but are more challenging to design. Subtype specific residues lining the ligand binding pocket will have to be taken into consideration.
Concluding remarks
In this review, common lessons among the three families of
LGICs have been emphasized. In all these LGICs, agonists induce closure of the binding pocket, whereas competitive antagonists seem to reverse the direction of motion; ligand size appears to be a key determinant of binding pocket motional direction. The gates of these LGICs all seem to be located at the outer portion of a helix, with outward tilting the likely gating motion (Box 2). For Cys loop receptors, the mechanism by which the binding pocket motion is transmitted to the gating motion has been controversial among many studies. Mechanistic models have recently been developed for the activation and desensitization of iGluRs [33] and P2XRs [4] . These probably will prompt additional studies and debate. The fact that the agonist-binding pocket can accommodate larger ligands (usually antagonists) means that some residues that could interact with ligands do not participate in interactions with agonists, and hence do not directly contribute to channel activation.
To move the field forward, integration of structure determination, functional study, and modeling and simulation will be important. Structures will continue to be the basis for modeling and simulation, and be indispensible for guiding functional studies. Modeling and simulation will be necessary to cover the chemical space of ligands and the subtype space of receptors. They can also be used to yield atomistic information on the activated state, which usually is too transient for structure determination. Structural comparison between the resting state and the activated state is valuable in many respects, in particular for understanding the action of allosteric modulators. Of course verification by functional studies remains essential.
